| Dr Jack Michael Becker, MD | |
|
233 E Lancaster Ave Ste 200, Ardmore, PA 19003 | |
| (610) 642-1643 | |
| Not Available |
| Full Name | Dr Jack Michael Becker |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 38 Years |
| Location | 233 E Lancaster Ave Ste 200, Ardmore, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851349955 | NPI | - | NPPES |
| 001252808 | Medicaid | PA | |
| 673732 | Other | PA | HIGHMARK PIN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | MDO42717E (Pennsylvania) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Main Line Allergy , L.l.p. | 0941284301 | 5 |
News Archive
Scientists are reporting development of a squishy gel that when compressed - like at a painful knee joint - releases anti-inflammatory medicine. The new material could someday deliver medications when and where osteoarthritis patients need it most. Their study appears in the ACS journal Biomacromolecules.
Low oxygen levels are a well-known cause of brain injury in premature babies. But the mechanism by which low oxygen hurts the developing human brain has been unclear.
Deletion of a protein in white blood cells improves their ability to fight the bacteria staphylococcus aureus and possibly other infections in mice with chronic granulomatous disease (CGD), according to a National Institutes of Health study. CGD, a genetic disorder also found in people, is marked by recurrent, life-threatening infections. The study's findings appear online in The Journal of Clinical Investigation.
Novasep, a leading supplier of services and technologies for the life sciences and chemical industries, and Celladon Corporation, a clinical-stage cardiovascular gene therapy company, today announce that they have signed a Development, Manufacturing and Supply Agreement pursuant to which, if supported by upcoming MYDICAR clinical data, Novasep would manufacture MYDICAR drug substance through 2018 with extension options through 2020.
› Verified 4 days ago
| Entity Name | Main Line Allergy , L.l.p. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437104460 PECOS PAC ID: 0941284301 Enrollment ID: O20040615000491 |
News Archive
Scientists are reporting development of a squishy gel that when compressed - like at a painful knee joint - releases anti-inflammatory medicine. The new material could someday deliver medications when and where osteoarthritis patients need it most. Their study appears in the ACS journal Biomacromolecules.
Low oxygen levels are a well-known cause of brain injury in premature babies. But the mechanism by which low oxygen hurts the developing human brain has been unclear.
Deletion of a protein in white blood cells improves their ability to fight the bacteria staphylococcus aureus and possibly other infections in mice with chronic granulomatous disease (CGD), according to a National Institutes of Health study. CGD, a genetic disorder also found in people, is marked by recurrent, life-threatening infections. The study's findings appear online in The Journal of Clinical Investigation.
Novasep, a leading supplier of services and technologies for the life sciences and chemical industries, and Celladon Corporation, a clinical-stage cardiovascular gene therapy company, today announce that they have signed a Development, Manufacturing and Supply Agreement pursuant to which, if supported by upcoming MYDICAR clinical data, Novasep would manufacture MYDICAR drug substance through 2018 with extension options through 2020.
› Verified 4 days ago
| Entity Name | Stc Pediatrics Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144864547 PECOS PAC ID: 7315372323 Enrollment ID: O20200122001254 |
News Archive
Scientists are reporting development of a squishy gel that when compressed - like at a painful knee joint - releases anti-inflammatory medicine. The new material could someday deliver medications when and where osteoarthritis patients need it most. Their study appears in the ACS journal Biomacromolecules.
Low oxygen levels are a well-known cause of brain injury in premature babies. But the mechanism by which low oxygen hurts the developing human brain has been unclear.
Deletion of a protein in white blood cells improves their ability to fight the bacteria staphylococcus aureus and possibly other infections in mice with chronic granulomatous disease (CGD), according to a National Institutes of Health study. CGD, a genetic disorder also found in people, is marked by recurrent, life-threatening infections. The study's findings appear online in The Journal of Clinical Investigation.
Novasep, a leading supplier of services and technologies for the life sciences and chemical industries, and Celladon Corporation, a clinical-stage cardiovascular gene therapy company, today announce that they have signed a Development, Manufacturing and Supply Agreement pursuant to which, if supported by upcoming MYDICAR clinical data, Novasep would manufacture MYDICAR drug substance through 2018 with extension options through 2020.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jack Michael Becker, MD Po Box 13579, Reading, PA 19612-3579 Ph: (484) 628-1324 | Dr Jack Michael Becker, MD 233 E Lancaster Ave Ste 200, Ardmore, PA 19003 Ph: (610) 642-1643 |
News Archive
Scientists are reporting development of a squishy gel that when compressed - like at a painful knee joint - releases anti-inflammatory medicine. The new material could someday deliver medications when and where osteoarthritis patients need it most. Their study appears in the ACS journal Biomacromolecules.
Low oxygen levels are a well-known cause of brain injury in premature babies. But the mechanism by which low oxygen hurts the developing human brain has been unclear.
Deletion of a protein in white blood cells improves their ability to fight the bacteria staphylococcus aureus and possibly other infections in mice with chronic granulomatous disease (CGD), according to a National Institutes of Health study. CGD, a genetic disorder also found in people, is marked by recurrent, life-threatening infections. The study's findings appear online in The Journal of Clinical Investigation.
Novasep, a leading supplier of services and technologies for the life sciences and chemical industries, and Celladon Corporation, a clinical-stage cardiovascular gene therapy company, today announce that they have signed a Development, Manufacturing and Supply Agreement pursuant to which, if supported by upcoming MYDICAR clinical data, Novasep would manufacture MYDICAR drug substance through 2018 with extension options through 2020.
› Verified 4 days ago
Dr. Sharon K Sweinberg, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 233 E Lancaster Ave, Suite 200, Ardmore, PA 19003 Phone: 610-642-1643 Fax: 610-642-0245 | |
Dr. Ruthven A. Wodell, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 233 E Lancaster Ave, Suite200, Ardmore, PA 19003 Phone: 610-642-1643 Fax: 610-642-0245 | |
A. Geoffrey Didario, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 233 E Lancaster Ave, Suite 200, Ardmore, PA 19003 Phone: 610-642-1643 Fax: 610-642-0245 | |
Dr. Jennifer Anita Kannan, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 233 E Lancaster Ave Ste 220, Ardmore, PA 19003 Phone: 610-642-1643 | |
Dr. Marc D Cotler, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 233 E Lancaster Ave, Suite 300, Ardmore, PA 19003 Phone: 610-642-3884 Fax: 610-642-3885 |